<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
Open Search
RPRX
Royalty Pharma
$
()


  • Royalty Pharma appoints Schneider as Chief Technology Officer

    9/21/2023 - 08:26am
  • Ascendis Pharma price target raised to $113 from $107 at BofA

    9/7/2023 - 06:26am
  • Ascendis Pharma and Royalty Pharma enter into $150M royalty funding pact

    9/5/2023 - 16:05pm
  • Royalty Pharma, Ferring Pharma sign $500M royalty agreement for Adstiladrin

    8/24/2023 - 06:34am
  • Royalty Pharma acquires royalty on U.S. sales of Adstiladrin for up to $500M

    8/24/2023 - 05:11am
  • Royalty Pharma raises 2023 adjusted cash reciepts guidance

    8/8/2023 - 07:19am
  • Royalty Pharma reports Q2 revenue $538M, consensus $536.59M

    8/8/2023 - 07:17am
  • Biotech Alert: Searches spiking for these stocks today

    5/26/2023 - 11:21am
  • Royalty Pharma CEO Legorreta buys 150,000 class A ordinary shares

    5/24/2023 - 18:48pm
  • Royalty Pharma director sells $57.4M in common stock

    5/23/2023 - 07:35am
  • Royalty Pharma reports Q1 revenue $684M, consensus $852.9M

    5/9/2023 - 07:09am
  • Royalty Pharma price target raised to $50 from $48 at Morgan Stanley

    4/10/2023 - 07:36am
  • Royalty Pharma price target raised to $60 from $57 at Tigress Financial

    4/6/2023 - 16:08pm
  • Royalty Pharma announces $1B share repurchase program

    3/27/2023 - 07:36am
  • Biotech Alert: Searches spiking for these stocks today

    3/24/2023 - 10:50am
dynamic_feed Breaking News